Archives of Cardiovascular Diseases Supplements, 2016
Background and aims CHA2DS2VASc score have been suggested to predict death in patients with Atria... more Background and aims CHA2DS2VASc score have been suggested to predict death in patients with Atrial Fibrillation (AF). In acute myocardial infarction (AMI), silent AF is common and associated with poor prognosis. In patients with AMI, we aimed to assess the CHA2DS2VASc score of patients with silent or symptomatic AF. Methods 849 consecutive AMI were prospectively analyzed by continuous ECG monitoring (CEM) 30 sec. Symptomatic AF was defined as any AF occurring on ECG during the hospital stay, resulting in clinical symptoms or need for urgent cardioversion. Results 135 (16%) developed silent AF and 45(5%) had symptomatic AF. Compared with the no AF group, patients with silent AF were markedly older (80 vs. 62 years; p Conclusion Patients with silent AF have level of CHA2DS2VASc risk similar to patients with symptomatic AF. A high CHA2DS2VASc score is associated with mortality, even when adjusted for GRACE risk score. These data suggest that CHA2DS2VASc score could improve risk stratification after AMI. The author hereby declares no conflict of interest
Archives of Cardiovascular Diseases Supplements, 2016
Background and aims CHA2DS2VASc score have been suggested to predict death in patients with Atria... more Background and aims CHA2DS2VASc score have been suggested to predict death in patients with Atrial Fibrillation (AF). In acute myocardial infarction (AMI), silent AF is common and associated with poor prognosis. In patients with AMI, we aimed to assess the CHA2DS2VASc score of patients with silent or symptomatic AF. Methods 849 consecutive AMI were prospectively analyzed by continuous ECG monitoring (CEM) 30 sec. Symptomatic AF was defined as any AF occurring on ECG during the hospital stay, resulting in clinical symptoms or need for urgent cardioversion. Results 135 (16%) developed silent AF and 45(5%) had symptomatic AF. Compared with the no AF group, patients with silent AF were markedly older (80 vs. 62 years; p Conclusion Patients with silent AF have level of CHA2DS2VASc risk similar to patients with symptomatic AF. A high CHA2DS2VASc score is associated with mortality, even when adjusted for GRACE risk score. These data suggest that CHA2DS2VASc score could improve risk stratification after AMI. The author hereby declares no conflict of interest
Uploads
Papers by Karim Stamboul